Success Metrics

Clinical Success Rate
33.3%

Based on 1 completed trials

Completion Rate
33%(1/3)
Active Trials
2(33%)
Results Posted
200%(2 trials)
Terminated
2(33%)

Phase Distribution

Ph phase_4
1
17%
Ph not_applicable
1
17%
Ph phase_3
1
17%
Ph phase_2
2
33%

Phase Distribution

0

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
2(40.0%)
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Completed(1)
Terminated(2)
Other(1)

Detailed Status

Terminated2
Recruiting1
unknown1
Active, not recruiting1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
33.3%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (40.0%)
Phase 31 (20.0%)
Phase 41 (20.0%)
N/A1 (20.0%)

Trials by Status

recruiting117%
unknown117%
active_not_recruiting117%
terminated233%
completed117%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
DRUG
Total Trials
6